These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11677135)

  • 1. Identification of a series of PPAR gamma/delta dual agonists via solid-phase parallel synthesis.
    Liu KG; Lambert MH; Leesnitzer LM; Oliver W; Ott RJ; Plunket KD; Stuart LW; Brown PJ; Willson TM; Sternbach DD
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2959-62. PubMed ID: 11677135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
    Etgen GJ; Oldham BA; Johnson WT; Broderick CL; Montrose CR; Brozinick JT; Misener EA; Bean JS; Bensch WR; Brooks DA; Shuker AJ; Rito CJ; McCarthy JR; Ardecky RJ; Tyhonas JS; Dana SL; Bilakovics JM; Paterniti JR; Ogilvie KM; Liu S; Kauffman RF
    Diabetes; 2002 Apr; 51(4):1083-7. PubMed ID: 11916929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
    Xu Y; Rito CJ; Etgen GJ; Ardecky RJ; Bean JS; Bensch WR; Bosley JR; Broderick CL; Brooks DA; Dominianni SJ; Hahn PJ; Liu S; Mais DE; Montrose-Rafizadeh C; Ogilvie KM; Oldham BA; Peters M; Rungta DK; Shuker AJ; Stephenson GA; Tripp AE; Wilson SB; Winneroski LL; Zink R; Kauffman RF; McCarthy JR
    J Med Chem; 2004 May; 47(10):2422-5. PubMed ID: 15115385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
    Henke BR; Blanchard SG; Brackeen MF; Brown KK; Cobb JE; Collins JL; Harrington WW; Hashim MA; Hull-Ryde EA; Kaldor I; Kliewer SA; Lake DH; Leesnitzer LM; Lehmann JM; Lenhard JM; Orband-Miller LA; Miller JF; Mook RA; Noble SA; Oliver W; Parks DJ; Plunket KD; Szewczyk JR; Willson TM
    J Med Chem; 1998 Dec; 41(25):5020-36. PubMed ID: 9836620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
    Dey D; Medicherla S; Neogi P; Gowri M; Cheng J; Gross C; Sharma SD; Reaven GM; Nag B
    Metabolism; 2003 Aug; 52(8):1012-8. PubMed ID: 12898466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.
    Lohray BB; Lohray VB; Bajji AC; Kalchar S; Poondra RR; Padakanti S; Chakrabarti R; Vikramadithyan RK; Misra P; Juluri S; Mamidi NV; Rajagopalan R
    J Med Chem; 2001 Aug; 44(16):2675-8. PubMed ID: 11472221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis.
    Guo Q; Sahoo SP; Wang PR; Milot DP; Ippolito MC; Wu MS; Baffic J; Biswas C; Hernandez M; Lam MH; Sharma N; Han W; Kelly LJ; MacNaul KL; Zhou G; Desai R; Heck JV; Doebber TW; Berger JP; Moller DE; Sparrow CP; Chao YS; Wright SD
    Endocrinology; 2004 Apr; 145(4):1640-8. PubMed ID: 14701675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
    Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
    Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
    Brown KK; Henke BR; Blanchard SG; Cobb JE; Mook R; Kaldor I; Kliewer SA; Lehmann JM; Lenhard JM; Harrington WW; Novak PJ; Faison W; Binz JG; Hashim MA; Oliver WO; Brown HR; Parks DJ; Plunket KD; Tong WQ; Menius JA; Adkison K; Noble SA; Willson TM
    Diabetes; 1999 Jul; 48(7):1415-24. PubMed ID: 10389847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
    Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
    Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryloxazolidinediones: identification of potent orally active PPAR dual alpha/gamma agonists.
    Desai RC; Gratale DF; Han W; Koyama H; Metzger E; Lombardo VK; MacNaul KL; Doebber TW; Berger JP; Leung K; Franklin R; Moller DE; Heck JV; Sahoo SP
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3541-4. PubMed ID: 14505666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture.
    Saluja I; Granneman JG; Skoff RP
    Glia; 2001 Mar; 33(3):191-204. PubMed ID: 11241737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis.
    Brown PJ; Stuart LW; Hurley KP; Lewis MC; Winegar DA; Wilson JG; Wilkison WO; Ittoop OR; Willson TM
    Bioorg Med Chem Lett; 2001 May; 11(9):1225-7. PubMed ID: 11354382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents.
    Desai RC; Han W; Metzger EJ; Bergman JP; Gratale DF; MacNaul KL; Berger JP; Doebber TW; Leung K; Moller DE; Heck JV; Sahoo SP
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2795-8. PubMed ID: 12873517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
    Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor agonists.
    Willson TM; Wahli W
    Curr Opin Chem Biol; 1997 Aug; 1(2):235-41. PubMed ID: 9667857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on 3D-QSAR of PPAR gamma agonists with thiazolidinedione and arylketo-acid moieties].
    Yi X; Guo ZR
    Yao Xue Xue Bao; 2001 Apr; 36(4):262-8. PubMed ID: 12580053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.
    Baylis C; Atzpodien EA; Freshour G; Engels K
    J Pharmacol Exp Ther; 2003 Dec; 307(3):854-60. PubMed ID: 14560039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphipathic 3-phenyl-7-propylbenzisoxazoles; human pPaR gamma, delta and alpha agonists.
    Adams AD; Yuen W; Hu Z; Santini C; Jones AB; MacNaul KL; Berger JP; Doebber TW; Moller DE
    Bioorg Med Chem Lett; 2003 Mar; 13(5):931-5. PubMed ID: 12617924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.